Inovio Pharmaceuticals Inc. closed 85.15% below its 52-week high of $14.75, which the company reached on April 1st.

What Else: Inovio's lead candidate, INO-4800, a DNA-based COVID-19 vaccine ... to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying ...

Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report)‘s stock had its “market outperform” rating restated by JMP Securities in a report issued on Friday,Benzinga reports. They currently have a $18.00 ...

Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting ...

Analysts at HC Wainwright upped their FY2024 earnings estimates for Inovio Pharmaceuticals in a research report issued on Monday, January 13th. HC Wainwright analyst R. Selvaraju now anticipates that ...

Inovio Pharmaceuticals Inc INO shares are trading higher by 17.9% ... ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock ...

The promising data on INO-3107’s efficacy and safety further underpins Buchanan’s positive outlook for the company’s stock. TipRanks tracks over 100,000 company insiders, identifying the ...

TORONTO, January 09, 2025--Inovalis Real Estate Investment Trust (the "REIT") (TSX: INO.UN) today announced the signing of an exchange contract for the sale of 87.5% of the Arcueil property to two ...

Nasdaq provides an interactive stock information chart to view history. Downloadable stock history data table is also accessible by clicking on Data Table on the navigation tool bar. If you have ...

This was the stock's second consecutive day of losses.